Improved glycemic control and reduced bodyweight with exenatide: A double‐blind, randomized, phase 3 study in Japanese patients with suboptimally controlled type 2 diabetes over 24 weeks

Aims/Introduction:  To evaluate the efficacy and safety of the glucagon‐like peptide‐1 receptor agonist, exenatide, in Japanese patients with type 2 diabetes mellitus suboptimally controlled despite therapeutic doses of a sulfonylurea alone or combined with a biguanide or thiazolidinedione. Material...

Descripción completa

Detalles Bibliográficos
Autores principales: Kadowaki, Takashi, Namba, Mitsuyoshi, Imaoka, Takeshi, Yamamura, Ayuko, Goto, Wakana, Boardman, Marilyn K., Sowa, Hideaki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 2010
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4014921/
https://www.ncbi.nlm.nih.gov/pubmed/24843486
http://dx.doi.org/10.1111/j.2040-1124.2010.00084.x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4014921/
https://www.ncbi.nlm.nih.gov/pubmed/24843486
http://dx.doi.org/10.1111/j.2040-1124.2010.00084.x

Ejemplares similares